Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC [NA]

View source ↗

Summary

Ongoing clinical trial evaluating electroacupuncture combined with a PD-1 inhibitor for advanced non-small cell lung cancer in patients with ECOG performance st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PD-1 inhibitor

Snippet

Sponsor: Kong Fanming | Conditions: Non-Small Cell Lung Cancer, Electroacupuncture | NA | Status: RECRUITING